Non-HLA immunogenetics in hematopoietic stem cell transplantation

Current Opinion in Immunology

Volumn 17, Issue 5, 2005, Pages 517-525

  Dickinson, Anne M ^a   Charron, Dominique ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HISTOCOMPATIBILITY ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ALLOGENEIC STEM CELL TRANSPLANTATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETICS; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY GENE; HLA MATCHING; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOGENETICS; INNATE IMMUNITY; OUTCOMES RESEARCH; REVIEW; RISK ASSESSMENT;

ANIMALS; CYTOKINES; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; IMMUNOGENETICS; POLYMORPHISM, GENETIC; TRANSPLANTATION IMMUNOLOGY;

EID: 23944460869     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2005.07.017     Document Type: Review

References (68)

1. A.M. Dickinson, P.G. Middleton, V. Rocha, E. Gluckman, and E. Holler Genetic polymorphisms predicting the outcome of bone marrow transplants Br J Haematol 127 2004 479 490
2. P. Reddy, and J.L.M. Ferrara Immunobiology of acute graft-versus-host disease Blood Rev 17 2003 187 194
3. E. Holler, B. Ertl, R. Hintermeier-Knabe, M.-G. Roncarolo, F. Eissner, F. Mayer, P. Fraunberger, U. Behrends, W. Pfannes, H.J. Kolb, and W. Wilmanns Inflammatory reactions induced by pretransplant conditioning - an alternative target for modulation of acute GvHD and complications following allogeneic bone marrow transplantation? Leuk Lymphoma 25 1997 217 224
4. E. Holler, M.-G. Roncarolo, R. Hintermeier-Knabe, G. Eissner, B. Ertl, U. Schulz, H. Knabe, H.J. Kolb, R. Andreesen, and W. Wilmanns Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation Bone Marrow Transplant 25 2000 237 241
5. P.G. Middleton, P.R.A. Taylor, G. Jackson, S.J. Proctor, and A.M. Dickinson Cytokine Gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants Blood 92 1998 3943 3948
6. J. Cavet, P.G. Middleton, M. Segall, H. Noreen, S.M. Davies, and A.M. Dickinson Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants Blood 94 1999 3941 3946
7. Y. Ishikawa, K. Kashiwase, K. Akaza, Y. Morishima, H. Inoko, T. Sasazuki, Y. Kodera, and T. Juji Polymorphisms in TNFA and TNFR2 affect outcome of unrelated bone marrow transplantation Bone Marrow Transplant 29 2002 569 575
8. L.J. Keen, T.E. DeFor, J.L. Bidwell, S.M. Davies, B.A. Bradley, and J.M. Hows Interleukin-10 and tumor necrosis factor alpha region haplotypes predict transplant-related mortality after unrelated donor stem cell transplantation Blood 103 2004 3599 3602 This is one of the first reports of TNF and IL-10 gene polymorphisms associating with transplant-related mortality in an matched unrelated donor setting.
9. A. Nordlander, M. Uzunel, J. Mattsson, and M. Remberger The TNFd4 allele is correlated to moderate-to-severe acute graft-versus-host disease after allogeneic stem cell transplantation Br J Haematol 119 2002 1133 1136
10. G.L. Stark, A.M. Dickinson, G.H. Jackson, P.R. Taylor, S.J. Proctor, and P.G. Middleton Tumour necrosis factor receptor type II 196M/R genotype correlates with circulating soluble receptor levels in normal subjects and with graft-versus-host disease after sibling allogeneic bone marrow transplantation Transplantation 76 2003 1742 1749
11. C.F. Spink, L.J. Keen, P.G. Middleton, and J.L. Bidwell Discrimination of suballeles present at the TNFd microsatellite locus using induced heteroduplex analysis Genes Immun 5 2004 76 79
12. M.T. Lin, B. Storer, P.J. Martin, L.H. Tseng, T. Gooley, P.J. Chen, and J.A. Hansen Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation N Engl J Med 349 2003 2201 2210
13. C. Mullighan, S. Heatley, K. Doherty, F. Szabo, A. Grigg, T. Hughes, A. Schwarer, J. Szer, B. Tait, and B. To Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation Transplantation 77 2004 587 596
14. G. Kögler, P.G. Middleton, M. Wilke, V. Rocha, B. Esendam, J. Enczmann, P. Wernet, E. Gluckman, S. Querol, and L. Lecchi Recipient cytokine genotypes for TNF-a and IL-10 and the minor histocompatibility antigens HY and CD31 codon 125 are not associated with occurrence or severity of acute GvHD in unrelated cord blood transplantation Transplantation 74 2002 1167 1175
15. G. Socié, P. Loiseau, R. Tamouza, A. Janin, M. Busson, E. Gluckman, and D. Charron Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation Transplantation 72 2001 699 705
16. D. Fishman, G. Faulds, R. Jeffry, V. Mohamed-Ali, J.S. Yudkin, S. Humphries, and P. Woo The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis J Clin Invest 102 1998 1369 1376
17. J. Cavet, A.M. Dickinson, J. Norden, Taylor PRA, G.H. Jackson, and P.G. Middleton Interferon-gamma and interleukin-six gene polymorphisms associate with graft versus host disease in HLA-matched sibling bone marrow transplantation Blood 98 2001 1594 1600
18. V. Pravica, A. Asderakis, C. Perrey, A. Hajeer, P. Sinnott, and I.V. Hutchinson In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene Eur J Immunogenet 26 1999 1 3
19. M.P. Reynard, D. Turner, M. Wadhwa, C. Bird, and C.V. Navarette The influence of IFN-gamma gene microsatellite on IFN-gamma production Immunology 61 2000 S138
20. W.J. Murphy, L.A. Welniak, D.D. Taub, R.H. Wiltrout, P.A. Taylor, D.A. Vallera, M. Kopf, H. Young, D.L. Longo, and B.R. Blazar Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice J Clin Invest 102 1998 1742 1748
21. Y.G. Yang, J. Qi, and M. Sykes IFN-gamma downmodulates graft-versus-host disease while mediating graft-versus-leukaemic effects Blood 94 1999 635a
22. A. Mlynarczewska, B. Wysoczanska, L. Karabon, K. Bogunia-Kubik, and A. Lange Lack of IFN-gamma 2/2 homozygous genotype independently of recipient age and intensity of conditioning regimen influences the risk of aGVHD manifestation after HLA-matched sibling haematopoietic stem cell transplantation Bone Marrow Transplant 34 2004 339 344
23. H.P. Brok, J.M. Vossen, and P.J. Heidt IFN-gamma-mediated prevention of graft-versus-host disease: pharmacodynamic studies and influence on proliferative capacity of chimeric spleen cells Bone Marrow Transplant 22 1998 1005 1010
24. A. Mlynarczewska, E. Jaskula, and K. Bogunia-Kubik Association between the IFN-gamma gene polymorphism and the risk of EBV infection in patients after allogeneic haematopoietic stem cell transplantation EBMT 237 2005 S39
25. H. Cullup, and G.L. Stark Interleukin-1 polymorphisms and graft-vs-host disease Leuk Lymphoma 46 2005 517 523 The authors comprehensively review IL-1 immunobiology and its role in GVHD.
26. H. Cullup, A.M. Dickinson, G.H. Jackson, Taylor PRA, J. Cavet, and P.G. Middleton Donor interleukin-1 receptor antagonist genotype associated with acute graft-versus-host disease in human leukocyte antigen-matched sibling allogeneic transplants Br J Haematol 113 2001 807 813
27. V. Rocha, R.F. Franco, R. Porcher, H. Bittencourt, W.A. Silva Jr., A. Latouche, A. Devergie, H. Esperou, P. Ribaud, and G. Socié Host defence and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplant Blood 100 2002 3908 3918
28. H. Cullup, A.M. Dickinson, J. Cavet, G.H. Jackson, and P.G. Middleton Polymorphisms of IL-1alpha constitute independent risk factors for chronic graft versus host disease following allogeneic bone marrow transplantation Br J Haematol 122 2003 778 787
29. M.L. MacMillan, G.A. Radloff, T.E. DeFor, D.J. Weisdorf, and S.M. Davies Interleukin-1 genotype and outcome of unrelated donor bone marrow transplantation Br J Haematol 121 2003 597 604
30. D.J. Grainger, K. Heathcote, M. Chiano, H. Snieder, P.R. Kemp, J.C. Metcalfe, N.D. Carter, and T.D. Spector Genetic control of the circulating concentration of transforming growth factor type beta 1 Hum Mol Genet 8 1999 93 97
31. H. Hattori, A. Matsuzaki, A. Suminoe, K. Ihara, Y. Nagatoshi, N. Sakata, K. Kawa, J. Okamura, and T. Hara Polymorphisms of growth factor-beta1 and transforming growth factor-beta 1 type II receptor genes are associated with acute graft-versus-host disease in children with HLA-matched sibling bone marrow transplantation Bone Marrow Transplant 30 2002 665 671
32. M.L. MacMillan, G.A. Radloff, W.R. Kiffmeyer, T.E. DeFor, D.J. Weisdorf, and S.M. Davies High-producer Interleukin-2 genotype increases risk for acute graft-versus-host disease after unrelated donor bone marrow transplantation Transplantation 76 2003 1758 1762
33. W.J. Jordan, P.A. Brookes, R.M. Szydlo, J.M. Goldman, R.I. Lechler, and M.A. Ritter IL-13 production by donor T cells is prognostic of acute graft-versus-host disease following unrelated donor stem cell transplantation Blood 103 2004 717 724
34. E. Goulmy Human minor histocompatibility antigens Curr Opin Immunol 8 1996 75 81
35. E. Goulmy, J.W. Gratama, E. Blokland, F.E. Zwaan, and J.J. van Rood A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft versus host disease Nature 302 1983 159 161
36. E. Goulmy, A. Termijtelen, B.A. Bradley, and J.J. van Rood Y-antigen killing by T cells of women is restricted by HLA Nature 266 1977 544 545
37. E. Goulmy, E. Blokland, J. van Rood, D. Charmot, B. Malissen, and C. Mawas Production, expansion, and clonal analysis of T cells with specific HLA-restricted male lysis J Exp Med 152 1980 182s 190s
38. L. Meadows, W. Wang, J.M. den Haan, E. Blokland, C. Reinhardus, J.W. Drijfhout, J. Shabanowitz, R. Pierce, A.I. Agulnik, and C.E. Bishop The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition Immunity 6 1997 273 281
39. W. Wang, L.R. Meadows, J. den Haan, N.E. Sherman, Y. Chen, E. Blokland, J. Shabanowitz, A.I. Agulnik, C.E. Bishop, and D. Hunt The human H-Y: A male-specific histocompatibility antigen derived from the SMCY protein Science 269 1995 1588 1590
40. S.S. Randolph, T.A. Gooley, E.H. Warren, F.R. Appelbaum, and S.R. Riddell Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants Blood 103 2004 347 352
41. M.H. Vogt, J.W. van den Muijsenberg, E. Goulmy, E. Spierings, P. Kluck, M.G. Kester, R.A. van Soest, J.W. Drijfhout, R. Willemze, and J.H. Falkenburg The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease Blood 99 2002 3027 3032
42. D.B. Miklos, H.T. Kim, E. Zorn, E.P. Hochberg, L. Guo, A. Mattes-Ritz, S. Viatte, R.J. Soiffer, J.H. Antin, and J. Ritz Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors Blood 103 2004 353 359
43. D.B. Miklos, H.T. Kim, K.H. Miller, L. Guo, E. Zorn, S.J. Lee, E.P. Hochberg, C.J. Wu, E.P. Alyea, and C. Cutler Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission Blood 105 2005 2973 2978 One of the first descriptions of antibody responses to minor histocompatibility antigens associated with chronic GvHD and disease remission.
44. M. de Bueger, A. Bakker, J.J. van Rood, F. Van Der Woude, and E. Goulmy Tissue distribution of human minor histocompatibility antigens (Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens.) J Immunol 149 1992 1788 1794
45. W.A. Marijt, M.H. Heemskerk, F.M. Kloosterboer, E. Goulmy, M.G. Kester, M.A. van der Hoorn, S.A. van Luxemburg-Heys, M. Hoogeboom, T. Mutis, and J.W. Drijfhout Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukaemia Proc Natl Acad Sci USA 100 2003 2742 2747
46. T. Mutis, R. Verdijk, E. Schrama, B. Esendam, A. Brand, and E. Goulmy Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens Blood 93 1999 2336 2341
47. C.A. Klein, M. Wilke, J. Pool, C. Vermeulen, E. Blokland, E. Burghart, S. Krostina, N. Wendler, B. Passlick, and G. Riethmüeller The hematopoietic system-specific minor histocompatibility antigen HA-1 shows aberrant expression in epithelial cancer cells J Exp Med 196 2002 359 368
48. B. Mommaas, J.A. Stegehuis-Kamp, A.G. van Halteren, M. Kester, J. Enczmann, P. Wernet, G. Kogler, T. Mutis, A. Brand, and E. Goulmy Cord blood comprises antigen-experienced T cells specific for maternal minor histocompatibility antigen HA-1 Blood 105 2005 1823 1827
49. C.G. Mullighan, S. Heatley, K. Doherty, F. Szabo, A. Grigg, T.P. Hughes, A.P. Schwarer, J. Szer, B.D. Tait, L. Bik To, and P.G. Bardy Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hematopoietic stem cell transplantation Blood 99 2002 3524 3529
50. E. Lorenz, D.A. Schwartze, P.J. Martin, T. Gooley, and M.T. Lin Chen Jw, Hansen JA, C lark JG:Association of TLR4 mutations and the risk for acute GVHD after HLA-matched -sibling hematopoietic stem cell transplantation Biol Blood Marrow Transplant 7 2001 384 387
51. E. Holler, G. Rogler, H. Herfath, J. Brenmoehl, P.J. Wild, H. Hahn, G. Eissner, J. Scholmerich, and R. Andreesen Both donor and recipient NOD2/CARD 15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation Blood 104 2004 889 894 This paper reports a major impact of NOD2/CARD 15 gene mutations in TRM and GvHD, which were previously found to be involved in susceptibility to Crohn's disease. The data suggest a monocyte/macrophage dysfunction.
52. P.G. Middleton, H. Cullup, A.M. Dickinson, J. Norden, G.H. Jackson, Taylor PRA, and J. Cavet Vitamin D receptor gene polymorphism associates with graft-versus-host disease and survival in HLA-matched sibling allogeneic bone marrow transplantation Bone Marrow Transplant 30 2002 223 228
53. P.G. Middleton, H. Cullup, J. Cavet, G.H. Jackson, Taylor PRA, and A.M. Dickinson Estrogen receptor alpha gene polymorphism associates with occurrence of graft versus host disease and reduced survival in HLA indentical sib-allo BMT Bone Marrow Transplant 32 2003 41 47
54. Tamouza R, Rocha V, Busson M, Fortier C, El Sherbini SM, Esperou H, Filion A, Socié G, Dulphy N, Krishnamoorthy R et al.: Association of HLA-E polymorphism with severe bacterial infection and early transplant-related mortality in matched unrelated bone marrow transplantation. Transplantation 2005, 79 in press.
55. R. Tamouza, M.G. Neonato, M. Busson, F. Marzais, R. Girot, D. Labie, J. Elion, and D. Charron infectious complications in sickle cell disease are influenced by HLA class II alleles Hum Immunol 63 2002 194 199
56. A. Gratwohl, R. Brand, J. Apperley, A. Biezen Av, G. Bandini, A. Devergie, A. Schattenberg, F. Frassoni, C. Guglielmi, and S. Iacobelli Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia Blood 100 2002 3877 3886
57. A. Gratwohl, J. Hermans, J.M. Goldman, W. Arcese, E. Carreras, A. Devergie, F. Frassoni, G. Gahrton, H.J. Kolb, and D. Niederwieser Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation Lancet 352 1998 1087 1092
58. D. Weisdorf, R. Hakke, B. Blazar, W. Miller, P. McGlave, N. Ramsay, J. Kersey, and A. Filipovich Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation Transplantation 51 1991 1197 1203
59. D. Niederwieser, M. Pepe, R. Storb, R. Witherspoon, G. Longton, and K. Sullivan Factors predicting chronic graft-versus-host disease and survival after marrow transplantation for aplastic anemia Bone Marrow Transplant 4 1989 151 156
60. E. Clave, V. Rocha, K. Talvensaari, M. Busson, C. Douay, M.L. Appert, C. Rabian, M. Carmagnat, F. Garnier, and A. Filion Pronognostic value of pretransplantation host thymic function in HLA-identical sibling hematopoietic stem cell transplantation Blood 105 2005 2608 2613
61. K. Talvensaari, E. Clave, C. Douay, C. Rabian, L. Garderet, M. Busson, F. Garnier, D. Douek, E. Gluckman, D. Charron, and A. Toubert A broad T cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation Blood 99 2002 1458 1464
62. H.M. Colhoun, P.M. McKeigue, and G. Davey Smith Problems of reporting genetic associations with complex outcomes Lancet 361 2003 865 872
63. J.M. Wu, D. Bensen-Kennedy, Y. Miura, C.J. Thoburn, D. Armstrong, G.B. Vogelsang, and A.S. Hess The effects of interleukin 10 and interferon gamma cytokine gene polymorphisms on survival after autologous bone marrow transplantation for patients with breast cancer Biol Blood Marrow Transplant 11 2005 455 464
64. J. Lacha, P. Hribova, K. Kotsch, I. Brabcova, K. Bartosova, H.D. Volk, and S. Vitko Effect of cytokines and chemokines (TGF-beta, TNF-alpha, IL-6, IL-10, MCP-1, RANTES) gene polymorphisms in kidney recipients on posttransplantation outcome: influence of donor-recipient match Transplant Proc 37 2005 764 766
65. H.X. Zheng, A. Zeevi, K. McCurry, E. Schuetz, S. Webber, J. Ristich, J. Zhang, A. Iacono, J. Dauber, and K. McDade The impact of pharmacogenomic factors on acute persistent rejection in adult lung transplant patients Transpl Immunol 14 2005 37 42 This is the first report of the association of a drug disposition genotype with drug resistant acute rejection in organ transplant patients.
66. W.E. Ollier Cytokine genes and disease susceptibility Cytokine 28 2004 174 178
67. R. Zeiser, R. Marks, H. Bertz, and J. Finke Immunopathogenesis of acute graft-versus-host disease: implications for novel preventive and therapeutic strategies Ann Hematol 83 2004 551 565
68. Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B: Hematopoietic cell transplantation-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005, in press. This paper describes a new tool for risk assessment in HSCT which may be widely applicable.